2025 annual financial data
Revolution Medicines 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -1,182,369,000 USD and net income was -1,131,301,000 USD.
Operating cash flow was -897,741,000 USD.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,182,369,000 USD
- Net income
- -1,131,301,000 USD
- Operating cash flow
- -897,741,000 USD